3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
2
OTHER
1
NETWORK
1
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Prostatic Neoplasms
103
Lymphoma, Large B-Cell, Diffuse
32
Neoplasms
23
Lymphoma, Non-Hodgkin
20
Lymphoma, Follicular
20
Lymphoma
19
Multiple Myeloma
15
Lymphoma, B-Cell
11
Neoplasm Metastasis
10
Recurrence
8
Lymphoma, T-Cell, Peripheral
7
Prostatic Neoplasms, Castration-Resistant
5
Prostate Cancer Metastatic
5
Metastatic Castration-resistant Prostate Cancer
5
Lymphoma, Mantle-Cell
5
Hematologic Diseases
5
Lymphoma, B-Cell, Marginal Zone
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Ovarian Neoplasms
3
Metastatic Castration-Resistant Prostate Cancer
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Colorectal Neoplasms
3
Triple Negative Breast Neoplasms
2
Pain
2
Metastatic Castration Resistant Prostate Cancer
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphatic Diseases
2
Leukemia
2
Graft vs Host Disease
2
Interventions
Fentanyl
13
Zoledronic Acid
8
Ibandronic Acid
8
nabiximols
6
Oxycodone
6
Tapentadol
5
Morphine
4
Hydromorphone
4
Cryotherapy
4
Cryosurgery
4
alvimopan
3
trimebutine 3-thiocarbamoylbenzenesulfonate
2
resiniferatoxin
2
cabozantinib
2
Tetrodotoxin
2
Radiation
2
Prednisone
2
Naloxone
2
Diclofenac
2
Analgesics, Opioid
2
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
ziconotide
1
oxycodone naloxone combination
1
imisopasem manganese
1
fulranumab
1
Xylitol
1
Ultracet
1
Transdermal Patch
1
Therapeutics
1
Sufentanil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Pain
×
Prednisone
×
Clear all
NCT01522443
2018-05-23
COMET-2
Exelixis
Phase 3
Terminated
119 enrolled
21 charts
NCT01605227
2018-03-14
COMET-1
Exelixis
Phase 3
Completed
1,028 enrolled
18 charts